ALTO NEUROSCIENCE INC (ANRO:NYSE)
$27.33 -0.49 (-1.7613%)
Analysed ALTO NEUROSCIENCE INC (ANRO:NYSE) News Sources
NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207
23-03-2026
yahoo.com
Alto Neuroscience CFO Nick Smith on Firm’s $120 Million Private Placement
23-03-2026
yahoo.com
Immunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJM
02-04-2026
biopharmadive.com
Update: Alto Neuroscience Shares Fall After Phase 2 Trial of ALTO-101 Yields Statistically Insignificant Data
02-04-2026
yahoo.com
Sector Update: Health Care Stocks Softer Late Afternoon
02-04-2026
yahoo.com
Top 1% Alto Neuroscience Plummets On Its Shocking Schizophrenia Miss
02-04-2026
yahoo.com
Alpha Wave Global Initiates COPT Defense Properties Position, According to Recent SEC Filing
27-05-2026
fool.com
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
15-06-2026
yahoo.com
Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment?
02-07-2026
yahoo.com
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
13-07-2026
yahoo.com
What is the current price of ALTO NEUROSCIENCE INC (ANRO:NYSE)?
The current price of ALTO NEUROSCIENCE INC (ANRO:NYSE) is $27.33.
ALTO NEUROSCIENCE INC (ANRO:NYSE) absolute price change since previous trading day?
The absolute price change of ALTO NEUROSCIENCE INC (ANRO:NYSE) since the previous trading day is $-0.49.
ALTO NEUROSCIENCE INC (ANRO:NYSE) percentage price change since previous trading day?
The percentage price change of ALTO NEUROSCIENCE INC (ANRO:NYSE) since the previous trading day is -1.7613%.
What is the most recent average sentiment score for ALTO NEUROSCIENCE INC (ANRO:NYSE)?
The most recent average sentiment score for ALTO NEUROSCIENCE INC (ANRO:NYSE) is 78 out of 100.
What is the most recent average sentiment for ALTO NEUROSCIENCE INC (ANRO:NYSE)?
The most recent sentiment for ALTO NEUROSCIENCE INC (ANRO:NYSE) is .
SEC-8K** Filing Available For ALTO NEUROSCIENCE INC (ANRO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.